UNSPSC 85523030: Occlusion of upper vein with intraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of upper vein with intraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05LY4DZ

UNSPSC 85523030 Occlusion of upper vein with intraluminal device, percutaneous endoscopic approach (Commodity) does not align with the state and local opportunities recently posted under this code. The code nominally describes a specific medical procedure involving intraluminal device placement in upper veins, yet the recent solicitations tagged to it span occupational health surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluations for pension disability determinations, surgical benefit carve-out programs, and emergency medical services for detained youth — none of which involve vascular intervention devices or procedures. The mismatch suggests either a data-classification error in the sourcing system or that state and local procurement offices are applying the code to capture medical services broadly rather than the discrete procedural intervention the code nominally describes.

The recent opportunities originate from diverse issuing bodies including state departments (Washington State Department of Transportation), counties (Harris County, Collier County, Santa Clara County), cities (Phoenix, Long Beach), and regional health systems, distributed across Washington, Arizona, California, Texas, and Florida with no geographic concentration. The only posted opportunity with a response date in the visible future is the Washington State Ferries occupational medical surveillance RFP (due October 9, 2026), while most others have passed or are imminently due. Given the code's procedural specificity and the complete absence of recent solicitations for vascular intervention services, this code shows little active state and local procurement activity relevant to device manufacturers or vascular specialists. Firms pursuing this code should verify that their target jurisdictions are actually soliciting vascular procedures before investing in business development under this designation.